No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Lagerlöf I, Holte H, Glimelius I, Björkholm M, Enblad G, Erlanson M, Fluge Ø, Fohlin H, Fosså A, Goldkuhl C, Gustavsson A, Johansson AS, Linderoth J, Nome O, Palma M, Åkesson L, Østenstad B, Raud C, Glimelius B, Molin D.
Lagerlöf I, et al. Among authors: gustavsson a.
Br J Haematol. 2020 Mar;188(5):685-691. doi: 10.1111/bjh.16232. Epub 2019 Oct 14.
Br J Haematol. 2020.
PMID: 31612478
Free article.
Clinical Trial.